Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alvaro Sanchez Arraez"'
Autor:
Pedro Berraondo, Sara Labiano, Luna Minute, Iñaki Etxeberria, Marcos Vasquez, Alvaro Sanchez-Arraez, Alvaro Teijeira, Ignacio Melero
Publikováno v:
OncoImmunology, Vol 6, Iss 5 (2017)
Lessons learned over decades on the use of gene and cell therapies have found clinical applicability in the field of cancer immunotherapy. On December 16th, 2016 a symposium was held in Pamplona (Spain) to analyze and discuss the critical points for
Externí odkaz:
https://doaj.org/article/be99535f192243099148c542643d55d4
Autor:
Paula Jiménez-Fonseca, Eduardo Castanon, Felipe Álvarez Manceñido, Alvaro Sanchez Arraez, Alberto Carmona-Bayonas
Publikováno v:
European Journal of Internal Medicine
Probably it does.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c42f3f0e92e351bd17543af0190223c
Autor:
Felipe Alvarez-Manceñido, Paula Jiménez-Fonseca, Alvaro Sanchez-Arraez, Eduardo Castanon, Alberto Carmona-Bayonas
Publikováno v:
European Journal of Cancer. 142:152-153
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ad0b747292d4699499c3bfb680cbb46
https://doi.org/10.1016/j.ejca.2020.10.003
https://doi.org/10.1016/j.ejca.2020.10.003
Autor:
Felipe Alvarez-Manceñido, Eduardo Castanon, Paula Jiménez-Fonseca, Alvaro Sanchez-Arraez, Alberto Carmona-Bayonas
Publikováno v:
European journal of cancer (Oxford, England : 1990). 136
The dynamic effects of immune checkpoint inhibitors (ICIs) are a challenge when designing and analysing data in non-proportional hazards (PH) scenarios. Herein, we present the risk of making type II errors, affecting pharmacotherapeutic development w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5c628681ee00daac947a182bdaf6d9d
https://pubmed.ncbi.nlm.nih.gov/33162285
https://pubmed.ncbi.nlm.nih.gov/33162285
Autor:
Elixabet Bolaños, Alvaro Sanchez-Arraez, Iñaki Etxeberria, Arantza Azpilikueta, Ignacio Melero, Maria E. Rodriguez-Ruiz, Alfonso R. Sánchez-Paulete, Alvaro Teijeira, David Sancho, Jose I. Quetglas, Cristian Smerdou, Pedro Berraondo, Sara Labiano, María Cristina Ballesteros-Briones, Sergio A. Quezada, Noelia Casares
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Instituto de Salud Carlos III (ISCIII)
Multiple lines of evidence indicate a critical role of antigen cross-presentation by conventional BATF3-dependent type 1 classical dendritic cells (cDC1) in CD8-mediated antitumor immunity. Flt3L and XCL1, respectively, constitute a key growth/differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b96de1915b6c6ea07e18757d9572160
https://hdl.handle.net/20.500.12105/9593
https://hdl.handle.net/20.500.12105/9593
Autor:
Alvaro Sanchez Arraez, Eduardo Castanon Alvarez, L. Resano, Covadonga Vidal, Antonio Gonzalez Martin, Mariano Ponz-Sarvise, Luis Barba
Publikováno v:
Journal of Clinical Oncology. 38:e14094-e14094
e14094 Background: Selection of patients for enrolment in phase I trials is critical. Initial scores (RMS or MDAS) were designed to select patients with higher probability to obtain benefit in a clinical trial, followed by others such as GRIM score a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a250aafa03aeec8883ee170ca88e7a17
https://doi.org/10.1200/jco.2020.38.15_suppl.e14094
https://doi.org/10.1200/jco.2020.38.15_suppl.e14094
Autor:
Jose Luis Perez-Gracia, Alvaro Sanchez-Arraez, David Sancho, Francisco J. Cueto, Alvaro Teijeira, Ignacio Melero, Saray Garasa, Alfonso R. Sánchez-Paulete
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 28(suppl_12)
Dendritic cells (DCs) are the main professional antigen-presenting cells for induction of T-cell adaptive responses. Cancer cells express tumor antigens, including neoantigens generated by nonsynonymous mutations, but are poor for antigen presentatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c7be423dfaf472fc235020e74302e0
https://pubmed.ncbi.nlm.nih.gov/28945841
https://pubmed.ncbi.nlm.nih.gov/28945841